Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endopeptidases (or endoproteases) are a subclass of proteolytic enzymes that cleave internal peptide bonds within protein chains, rather than removing amino acids from the ends[7]. They are critical to the degradation and processing of proteins in biological systems, and play essential roles in digestion, cell signaling, immune responses, cell cycle control, tissue remodeling, and the activation of other proteins (zymogens)[4][2][3][7]. Examples include trypsin, chymotrypsin, and pepsin, each with distinct substrate specificities[7][6]. Dysregulation of endopeptidase activity is implicated in a range of diseases, making them important therapeutic targets and biomarkers[4].\n\nNote: The term "Endoprotease enzyme" is non-specific—there are hundreds of unique enzymes that fit this category. For structured data as required by biomedical informatics, a specific enzyme name (such as "Trypsin" or "HIV-1 protease") would be necessary for proper annotation[5][7][4].
Competitive inhibition of the active site serine/cysteine/aspartic/metallo group\nAllosteric inhibition\nIrreversible (covalent) inhibition\nZymogen activation blockade
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endopeptidase (or Endoproteinase).